Friday 12 June |
Katoro Gold |
Informa |
Bakkavor |
Capital Drilling |
Monday 15 June |
IQ-AI |
Mirriad Advertising |
Tuesday 16 June |
Marshall Motor |
Clearstar |
Epwin Group |
Coca-Cola HBC |
Science Group |
Altus Strategies |
Arbuthnot Banking |
Evraz |
Andrews Sykes Group |
FDM Group |
Wednesday 17 June |
Amigo Holdings (re board removal) |
RTC Group |
Wentworth Resources |
STM Group |
Salt Lake Potash |
Domino's Pizza Group |
Pelatro |
UK Oil & Gas |
G4S |
Thursday 18 June |
Ted Baker (re share placing) |
IP Group |
Horizon Discovery |
Ten Entertainment |
Shield Therapeutics |
Tremor International |
Jadestone Energy |
Vietnam Enterprise |
Intelligent Ultrasound Group |
Block Energy |
RBG Holdings |
Impact Healthcare |
Michelmersh |
Immupharma |
Copyright 2020 Alliance News Limited. All Rights Reserved. |
IN BRIEF: ImmuPharma receives response for FDA for Lupuzor
ImmuPharma PLC - specialist drug discovery and development company - Says its US partner for Lupuzor, Avion Pharmaceuticals LLC, has received a written response from the US Food & Drug Administration that provided detailed guidance on the next steps for the drug's clinical programme. This included advice on the dosing regime, as well as guidance on the study protocol that can be amended to improve the regulatory outcome.
Read more